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Abstract
Background: Overuse injuries are reported to be more common than acute trauma in children and adolescents,
causing pain and reduced function. The most common is apophysitis - a traction injury to the apophysis in
growing individuals. The duration of symptoms reported in the literature is between 6 weeks to 6 months or more.
The objective of this systematic review and network meta-analysis is to compare the effectiveness and safety of all
available treatments for any type of apophysitis in children and adolescents.
Methods/Design: We will conduct a systematic review to retrieve all relevant studies applying a comparative
design. Searches will be made in the Cochrane CENTRAL, MEDLINE, EMBASE, CINAHL and SportDiscus databases
and via reference searching. The efficacy of treatments will be compared with respect to the outcomes 1) time to
pain-free activity and 2) risk of subsequent injury. Risk of bias assessment will be made using revised tool for
assessing risk of bias in randomized trials for Randomized trials and Robins-I tool for non-randomized trials. We will
explore if different treatment comparisons are sufficiently similar in terms of effect modifiers (transitivity
assumption) with the aim to conduct network meta-analyses for randomized and non-randomized studies
separately. A treatment hierarchy will be obtained using the surface under the cumulative ranking curve (SUCRA)
and mean ranks, visualized using rankograms. We will use the CINeMA software to apply the modified version of
Grades of Recommendation, Assessment, Development and Evaluation (GRADE), developed specifically to evaluate
the quality of evidence in network meta-analysis.
Discussion: To date the comparative effects of interventions for apophysitis seem to rely mainly on expert opinion.
We aim to identify all comparative treatment designs described in the literature and synthesize data when possible.
We will use the estimated treatment effects between injury locations to provide guidance in managing apophysitis.
Trial registration: PROSPERO ID number: CRD42018083746.
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Background
Overuse injuries are reported to be more common than
acute trauma in children and adolescent, causing pain
and reduced function [1]. In this population the most
frequent overuse injuries are apophysitis, a traction in-
jury to the apophysis with common names such as
Osgood-Schlatters disease, Sever’s disease, and Pitchers
elbow [2]. For example Osgood-Schlatters disease, an
apophysitis at the patellar tendon’s attachment to the
tibial tuberosity, has been reported to last more than
6 months [3], a period in which physical activity is re-
stricted because of pain. Thus, the motivation for sports
and physical activity may decrease, resulting in risk of
obesity and later on various lifestyle diseases [4].
The apophysis consists of three chondrocyte zones:
The resting germinal or stem cells represent the reserve
zone, which is located adjacent to the apophysis. It con-
sists of irregularly stacked chondrocytes and demon-
strates a low rate of proliferation. This zone is critical
because injury can result in growth cessation. The rest-
ing germinal cells enter the second proliferative zone.
The proliferative zone consists of stacked columnar
chondrocytes. These activated cells produce the extracel-
lular matrix for longitudinal growth via active cell div-
ision. The chondrocytes hypertrophy and travel further
from the apophysis into the third hypertrophic zone
which is not involved in active growth; rather, it is re-
sponsible for maturation, degeneration, and provisional
calcification. The hypertrophic zone is the weakest zone
in the apophysis and is the site most often involved in
alterations as widening and in the rare cases of avulsion
fractures. Apophyseal stresses in overuse injuries have
several potential sequelae including physeal widening,
early calcification, avulsion fractures, and premature
closure [5].
Injury to the vascularity of the apophysis can lead to dis-
ruption of the normal cycle of chondrocyte-programmed
cell death and subsequent ossification. Radiographic find-
ings are demineralization, fragmentation and apophyseal
widening, and in some cases hypertrophy and bone
prominence (e.g. tuberositas tibia in Osgood-Slater).
These findings are usually not permanent and are
expected to resolve with adjustment of activity, except for
the bony prominence [6].
In a recent clinical overview by Arnold and colleagues
[2], the interventions for apophysitis are discussed, but
no attempt on quantitative data synthesis has been
made.
The objective of this systematic review and network
meta-analysis is to compare the effectiveness and safety
of all available treatments for any type of apophysitis in
children and adolescent. We will compare the efficacy of
treatments with respect to the outcomes 1) time to
pain-free activity and 2) risk of subsequent injury. We
will follow the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines for
Network Meta-Analyses [7].
Methods
Criteria for considering studies for this review
Types of studies
Our initial strategy will be to include all studies that
provide longitudinal data from a comparative design on
any of our primary or secondary outcomes. As we do
not expect many randomized controlled trials we will in-
clude non-randomized comparative designs such as pro-
spective cohort studies (including nested case-control
analyses), historical cohort studies (including nested
case-control analyses) and Non-nested case-control
study design.
Types of participants
Participants must be 17 years of age or younger at the
time of diagnosis. We will include studies involving both
sexes, with apophysitis at any location.
Types of interventions
We will include studies examining any intervention for
an apophysitis at any location. We are aware that the
following treatments could currently be used by
clinicians in clinical practice: usual care (wait and see),
specific exercises, reduction of specific physical activity,
taping, bracing, manual therapy, joint or tissue
mobilization, dry needling, cryotherapy, electrical modal-
ities, medication and surgery. The interventions are
further described in ‘Additional file 1 description of
interventions’.
Types of outcome measures
Our primary outcome will be the duration of treatment
from start of treatment until return to previous activity
level without pain. If this is not provided in a particular
study, we will still consider return to previous activity
with or without pain as an equivalent outcome. Our
secondary outcomes include: Time from treatment initi-
ation to return to sport, risk of any subsequent injury
(any location, any type - including acute and overuse
injuries and risk of subsequent injury to the same loca-
tion of the same type) and risk of recurrent injury (same
location and same type) [8]. We define a subsequent or
recurrent injury as a musculoskeletal injury as a result
physical activity that requires treatment from a clinician.
Search methods for identification of studies
We will search the following databases: Cochrane CEN-
TRAL, MEDLINE, EMBASE, CINAHL and SportDiscus.
We will search the references of all retrieved articles and
conduct a citation search of key articles retrieved from
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our primary searches for potentially relevant titles.
Papers written in English, Danish, Swedish, Norwegian
and German will be included.
Search strategy
Our search strategy combines three constructs: treat-
ment/rehabilitation, apophysitis, and children/adoles-
cents. ‘Additional file 2 search strategy’ describes our
currently planned search strategy. If this strategy appears
to identify many non-applicable types of articles, we will
adapt the strategy to restrict its focus. Similarly, the
search strategy will be adapted if the reference search
provides many relevant studies, undetected by the
original strategy.
Data collection and analysis
Selection of studies
The same two people (SLM, RTL) will review the titles
and abstracts to select eligible studies; discrepancies at
any stage will be resolved via consensus and will include
the remaining co-investigators of our study if necessary.
The reviewers will independently read all titles retrieved
from the search strategy to exclude any obviously
non-relevant papers. SLM and RTL will then review all
abstracts where titles were included by one of the ab-
stractors, and document the reasons why a particular
study is excluded. The reviewers will then review the full
articles, considered relevant by one of the abstractors,
and document the reasons why if the paper is excluded
at this stage.
We will extract the following study level characteris-
tics: lead author, year of publication, journal, setting (e.g.
hospital, private clinic), intervention details (such as
medication, exercise, manual therapy and surgery) and
outcome measures. We will extract data on participant
level characteristics: age, gender, onset of puberty (yes/
no), sport/physical activity, time to treatment, injury lo-
cation, severity of injury, time to return to activity, time
to return to pain-free activity, subsequent injury risk for
any injury or recurrent injury (see outcomes) and
number of dropouts including reason for dropout (if
mentioned). Data extraction will be carried out inde-
pendently by SLM and RTL using standard data extrac-
tion forms. Data will be cross checked between
reviewers. The extracted data will be discussed in case of
discrepancy between the reviewers and differences will
be resolved by the same consensus process as above.
Data on potential effect modifiers
Clinical features we believe may affect efficacy of
treatments are: age, gender, onset of puberty (defined by
Tanner stage [9]), sport/physical activity, time to treat-
ment, treatment dosage, if exercises are primarily super-
vised or homebased, injury location, severity and study
type. The effects of these features may differ between
injury locations. We will collect data on all of these
variables as noted in the preceding section.
Assessment of risk of bias in included studies
For randomized controlled trials, we will assess the risk
of bias with the revised tool for assessing risk of bias in
randomized trials [10]. Two independent reviewers will
assess all domains including bias arising from
randomization process, deviations from intended inter-
ventions, missing outcome data, measurement of the
outcome, selection of the reported result and other
biases particular to special study designs. Each risk of
bias item will receive either “low”, “some concerns” or
“high” risk of bias, and each judgement will include a
support statement as recommended by the tool. Discrep-
ancies will be resolved by consensus and will include the
remaining co-investigators of our study if necessary.
For non-randomized studies, we will use the
ROBINS-I tool [11] to assess the risk of bias in each of
the following seven domains: Bias due to confounding,
selection of participants into the study, classification of
interventions, deviations from intended interventions,
missing data, measurement of outcomes and selection
of the reported result. The categories for risk of bias
judgements are “Low risk”, “Moderate risk”, “Serious
risk” and “Critical risk” of bias. Importantly, “Low
risk” corresponds to the risk of bias in a high quality
randomized trial [11]. The assessment will be per-
formed independently by two raters and discrepancies
will be resolved via consensus and will include the
remaining co-investigators of our study if necessary.
Measures of treatment effect
Relative treatment effects
The main outcome: days until pain-free activity will be
expressed as mean differences. We will calculate the risk
of subsequent injury (over the time periods provided in
the original studies) for both treatment groups. For
dichotomous outcomes, we will report risk ratios, risk
differences and number needed to treat. For continuous
outcomes, we will report mean differences unless the
outcome is measured differently across studies in which
case we will report standardized mean differences. We
will perform a network meta-analysis [12, 13], which is a
method that synthesizes direct and indirect evidence
and allows us to compare the relative effectiveness
between treatments that have never been compared
head-to-head. Results from network meta-analysis will
be presented as summary relative effect sizes (mean
differences or odds ratios (OR)) for each possible pair of
interventions. We will produce summary results for all
outcomes and give the respective 95% confidence intervals
(95% CI). We will use restricted maximum likelihood to
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estimate heterogeneity assuming that heterogeneity is
common in all treatment comparisons. If we have skewed
data, we will use the methods presented by Higgins et al.
to pool results [14].
Relative treatment ranking
We will estimate the ranking probabilities for all treat-
ments of being at each possible rank for each interven-
tion. Then, we will obtain a treatment hierarchy using
the surface under the cumulative ranking curve
(SUCRA) and mean ranks, visualized using rankograms
[15]. The SUCRA statistics will be interpreted with refer-
ence to the corresponding relative effects and 95% CI
between two treatments. This will also ensure that
differences are clearly visualized and their clinical
importance is taken into account.
Unit of analysis issues
We will extract summary data but our unit of analysis is
the individual participant. If there are any cross over
studies, we will use both periods if the study provides
evidence that there was no carry-over effect in their
study design, and use only the first period if this evi-
dence was not provided. Results from cluster random-
ized trials will be included with individual participant as
unit of analysis. In case of errors in the studies, we will
recalculate the standard errors on the effect size where
possible.
Dealing with missing data
We will report missing data and reasons for dropout in
all included studies. Whenever there are missing data in
the original papers, we will contact the authors to obtain
whatever information is possible. If we deem that
reasons for dropout are related to the outcomes, we will
consider the study to be at high risk of bias. If studies
have used single imputation techniques (such as last
observation carried forward, mean imputation etc.) we
will consider the study to be at high risk of bias. In such
cases, we will conduct a sensitivity analysis using a
pattern mixture model [16, 17] to evaluate how robust
results are to departures from the missing at random
assumption.
Assessment of clinical and methodological heterogeneity
within treatment comparisons
We will assess the presence of clinical heterogeneity
within each pairwise comparison by describing the trial
and study population characteristics across all eligible
trials.
Assessment of transitivity across treatment comparisons
The transitivity assumption, which is the underlying as-
sumption for network meta-analysis, will be assessed by
comparing the distribution of potential effect modifiers
across each different pairwise comparison. If a common
comparator in a Network differs from one pair-wise
comparison to another the transitivity assumption is
violated and the validity of the network meta-analysis
results is compromised [12].
Data synthesis
We will first analyze randomized studies and observa-
tional studies separately. For observational studies, we
will use adjusted measures when provided and
appropriate.
Methods for direct treatment comparisons
First, we will conduct pair-wise meta-analyses by synthe-
sizing studies that compare interventions, regardless of
injury location. The same pairwise meta-analyses will be
performed in interventions for a specific injury location
(e.g. knee, heel or elbow) using a random-effects model
if sufficient studies are available. All statistics will be
conducted in STATA (StataCorp. 2011. Statistical soft-
ware: Release 14. College Station, TX).
Methods for indirect and mixed comparisons
We assume that any patient that meets the inclusion
criteria is, in principle, equally likely to be randomized
to any of the eligible interventions. We hope to conduct
a network meta-analysis provided we are able to collect
sufficient data. If not, we will conduct standard
meta-analyses with meta-regression (where appropriate)
for particular treatment comparisons both overall and
separate anatomic locations (e.g. knee, heel or elbow),
and a qualitative evidence synthesis where meta-analyses
are not appropriate. We will perform network
meta-analysis using STATA (StataCorp. 2011. Statistical
software: Release 14. College Station, TX) using the
network package [18] and self-programmed STATA
routines [19] available at http://mtm.uoi.gr.
Assessment of statistical heterogeneity
We will explore whether treatment effects for our
primary outcomes are robust in subgroup analyses and
network meta-regression using the following characteris-
tics: Age, gender, onset of puberty, sport/physical activ-
ity, time to treatment, treatment dosage, if exercises are
primarily supervised or homebased, injury location,
severity, and study type. We will analyze each character-
istic separately and finally include in a meta-regression
those characteristics that were found to be statistically
significant in the univariate analyses.
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Assumptions when estimating the heterogeneity
In standard pairwise meta-analyses we will estimate
different heterogeneity variances for each pairwise com-
parison within a random effects model framework.
Measures and tests for heterogeneity
We will assess the presence of heterogeneity within each
pairwise comparison using the I2 (percentage of variabil-
ity that is due to differences in the underlying effects
across studies) and τ 2 statistics.
The assessment of statistical heterogeneity in the
entire network will be based on the magnitude of τ2-
estimated from the network meta-analysis models. For
dichotomous outcomes the magnitude of the heterogen-
eity variance will be compared with the empirical
distribution [20]. We will also estimate a total I2 value
for heterogeneity in the network as described elsewhere.
Assessment of statistical inconsistency
Local approaches for evaluating inconsistency
To evaluate the presence of inconsistency locally we will
use the loop-specific approach. This method evaluates
the consistency assumption in each closed loop of the
network separately as the difference between direct and
indirect estimates for a specific comparison in the loop
(inconsistency factor). Then, the magnitude of the
inconsistency factors and their 95% CIs can be used to
infer about the presence of inconsistency in each loop.
We will assume a common heterogeneity estimate
within each loop. We will present the results of this
approach graphically in a forest plot using the ifplot
command in STATA.
Global approaches for evaluating inconsistency
To check the assumption of consistency in the entire
network we will use the ‘design-by-treatment’ model as
described by Higgins and colleagues [21].
Investigation of heterogeneity and inconsistency
If we find important heterogeneity or/and inconsistency,
we will explore the possible sources. If sufficient studies
are available, we will perform meta-regression or sub-
group analyses by using the following effect modifiers as
possible sources of inconsistency and or heterogeneity:
age, gender, onset of puberty, sport/physical activity,
time to treatment, injury location, severity and study
type.
Sensitivity analysis
Our primary analysis will include all studies retrieved
through the search strategy described above. In sensitiv-
ity analyses, we will exclude [1] studies not reporting SD
rather than imputed, [2] studies at high or unclear risk
of bias and [3] outlying studies.
Quality of evidence
We will use a modified version [22] of Grades of Recom-
mendation, Assessment, Development and Evaluation
(GRADE), developed specifically to evaluate the quality
of evidence in network meta-analysis. For confidence in
specific pairwise effect and treatment rankings estimated
in the network meta-analysis the following domains will
be evaluated: Study limitations, indirectness, inconsist-
ency, imprecision, and publication bias. The starting
point for confidence in each network estimate is high,
but will be downgraded according to the assessments of
these five domains. The GRADE process will be com-
pleted using the CINeMA software, developed by the
Cochrane Statistics Methods Group for evaluating confi-
dence in the results of network meta-analysis [22, 23].
Discussion
Despite the high incidence of overuse injuries in children
and adolescent [24] the comparative treatment effects
for apophysitis seems to rely mainly on expert opinions
[2]. Therefore, the objective of this systematic review
and network meta-analysis is to compare the effective-
ness and safety of all available treatments for any type of
apophysitis in children and adolescent.
To identify all comparative treatment designs de-
scribed in the literature, we chose a broad search strat-
egy. We prefer to restrict the studies to high quality
randomized controlled trials. However, as we do not ex-
pect many of these, we will include other comparative
designs such as different types of cohort studies and case
control studies. We will prioritize studies of high
methodological quality. This strategy will able us to
collect the most relevant research within the area of
apophysitis.
Compared to the recent review by Arnold et al. [2] on
the same topic, the current study implements a much
broader search strategy as described in Additional file 2,
and our strategy for data synthesis, including a network
analysis, that will enable us to compare interventions if
they use a common comparator. Further we plan to up-
date our review using the present study protocol every
3rd year if more relevant research has been published,
which will keep researchers and clinicians updated on
the subject.
Our main outcome is time from treatment initiation
to previous activity level without pain, which we believe
is the most relevant outcome for patients, clinicians,
trainers and etcetera. We expect to identify common
patterns of treatment effects between injury locations, in
order to guide clinicians in managing apophysitis.
A possible limitation to our study is the current
quality of the evidence that appears to be generally low
according to Arnold et al. [2]. Thus we might end up
with very few studies for our network analysis.
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